Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial

Publication | Closed Access

DOI

3.8K

Citations

References

2003

Year

Peter Sever, Björn Dahlöf, Neil R Poulter, Hans Wedel, Gareth Beevers, Mark J. Caulfield, Rory Collins, Sverre E. Kjeldsen, Arni Kristinsson, Gordon T. McInnes,

The Lancet

ThrombosisHypertensionCardiovascular DiseaseHypertensive PatientsMedicineLower-than-average Cholesterol ConcentrationsHyperlipidemiaDyslipidemiaPreventive CardiologyPublic HealthStrokeCardiologyEpidemiologyCoronary Artery DiseaseCardiovascular Disease Risk Assessment